Safety and pharmacokinetics of imaradenant (AZD4635) in Japanese patients with advanced solid malignancies: a phase I, open-label study.
Nobuaki MatsubaraShota KusuharaNoboru YamamotoKazuki SudoMasahiko YanagitaKosho MurayamaHisashi KawasumiDeanna L RussellDa YinToshio ShimizuPublished in: Cancer chemotherapy and pharmacology (2023)
gov identifier NCT03980821 (June 10, 2019).